Mitogen-activated protein kinases and asthma

Journal of Cellular Physiology

Volumn 202, Issue 3, 2005, Pages 642-653

  Pelaia, Girolamo ^a,c   Cuda, Giovanni ^a   Vatrella, Alessandro ^b   Gallelli, Luca ^a   Caraglia, Michele ^b   Marra, Monica ^b   Abbruzzese, Alberto ^b   Caputi, Mario ^b   Maselli, Rosario ^a   Costanzo, Francesco S ^a   Marsico, Serafino A ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c Policlinico Mater Domini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTRANSMITTER; STRESS ACTIVATED PROTEIN KINASE;

AIRWAY; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; ENZYME ACTIVATION; EOSINOPHIL; HUMAN; INFLAMMATION; LUNG FUNCTION; MAST CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; T LYMPHOCYTE ACTIVATION;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHI; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; IMMUNE SYSTEM; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR STRUCTURE;

EID: 19944432162     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20169     Document Type: Review

References (133)

1. Adachi T, Choudhury BK, Stafford S, Sur S, Alam R. 2000. The differential role of extracellular-signal regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. J Immunol 165:2198-2204.
2. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR. 2000. Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6:109-116.
3. Adams JL, Badger AM, Kumar S, Lee JC. 2001. p38 MAP kinase: Molecular target for the inhibition of proinflammatory cytokines. Prog Med Chem 38:1-60.
4. Adcock IM, Lane SJ. 2003. Corticosteroid insensitive asthma: Molecular mechanisms. J Endocrinol 178:347-355.
5. Amrani Y, Ammit AJ, Panettieri RA, Jr. 2001. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: Role of p38 and p42/44 mitogen-activated protein kinases. Mol Pharmacol 60:646-655.
6. Ayala JM, Goyal S, Liverton NJ, Claremon DA, O'Keefe SJ, Hanlon WA. 2000. Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway. J Leukoc Biol 67:869-875.
7. Bantel H, Schmitz ML, Raible A, Gregor M, Schulze-Osthoff K. 2002. Critical role of NF-κB and stress-activated protein kinases in steroid unresponsiveness. FASEB J 16:1832-1834.
8. Barnes PJ, Adcock IM. 2003. How do corticosteroids work in asthma? Ann Intern Med 139:359-370.
9. Barnes PJ, Greening AP, Crompton GK. 1995. Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 152:S125-S140.
10. Barnes PJ, Pedersen S, Busse WW. 1998. Efficacy and safety of inhaled corticosteroids: New developments. Am J Respir Crit Care Med 157:S1-S53.
11. 4 biosynthesis. J Biol Chem 275:10968-10975.
12. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. 2001. SP600125, an anthrapyrazolone inhibitor of jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686.
13. Blease K, Lewis A, Raymon HK. 2003. Emerging treatments for asthma. Expert Opin Emerg Drugs 8:71-81.
14. Boehme SA, Sullivan SK, Crowe PD, Santos M, Conlon PJ, Sriramarao P, Bacon KB. 1999. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J Immunol 163:1611-1618.
15. Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ. 1992. Detection of alveolar macrophage-derived IL-1β in asthma: Inhibition with corticosteroids. J Immunol 149:3078-3082.
16. Boulton TG, Nye SH, Robbins DJ, Ny I, Radziejew-Ska E, Morgenbesser SD, Depinho RA, Panayotatos N, Cobb MH, Yancopoulos GD. 1991. ERKS: A family of protein serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675.
17. Bucchieri F, Puddicombe SM, Lordan JL, Richter A, Buchanan D, Wilson SJ, Ward J, Zummo G, Howarth PH, Djukanovich R, Holgate ST, Davies DE. 2002. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol 27:179-185.
18. Busse WW, Lemanske RF, Jr. 2001. Asthma. N Engl J Med 344:350-362.
19. Caelles C, Gonzalez-Sancho JM, Munoz A. 1997. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev 11:3351-3364.
20. Catena E, Mazzarella G, Peluso GF, Micheli P, Cammarata A, Marsico SA. 1993. Phenotypic features and secretory pattern of alveolar macrophages in atopic asthmatic patients. Monaldi Arch Chest Dis 48:6-15.
21. Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA. 1993. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 147:291-295.
22. Chang L, Karin M. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37-40.
23. Chen C-H, Zhang D-H, LaPorte JM, Ray A. 2000. Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: Phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J Immunol 165:5597-5605.
24. Chetta A, Zanini A, Foresi A, Del Donno M, Castagnaro A, D'Ippolito R, Baraldo S, Testi R, Saetta M, Olivieri D. 2003. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am J Respir Crit Care Med 167:751-757.
25. Chow C-W, Dong C, Flavell R, Davis R. 2000. JNK inhibits targeting of protein phosphatase calcineurin to NFATc1. Mol Cell Biol 20:5227-5234.
26. Clark AR. 2003. Mechanisms of steroid action and resistance in inflammation. MAP kinase phosphatase 1: A novel mediator of biological effects of glucocorticoids? J Endocrinol 178:5-12.
27. Clark AR, Lasa M. 2003. Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr Opin Pharmacol 3:404-411.
28. Cuda G, Paternò R, Ceravolo R, Candigliota M, Perrotti N, Perticone F, Faniello MC, Schepis F, Ruocco A, Mele E, Cassano S, Bifulco M, Santillo M, Avvedimento VE. 2002. Protection of human endothelial cells from oxidative stress: Role of Ras-ERK1/2 signaling. Circulation 105:968-974.
29. Devalia JL, Bayram H, Abdelaziz MM, Sapsford RJ, Davies RJ. 1999. Differences between cytokine release from bronchial epithelial cells of asthmatic patients and non-asthmatic subjects: Effects of exposure to diesel exhaust particles. Int Arch Allergy Immunol 118:437-439.
30. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282:2092-2095.
31. Dong C, Davis RJ, Flavell R. 2002. MAP kinases in the immune response. Annu Rev Immunol 20:55-72.
32. Dumas J, Sibley E, Riedl B, Monahan MK, Lee W, Lowinger TB, Redman AM, Johnson JS, Kingery-Wood J, Scott WJ, Smith RA, Bobko M, Schoenleber R, Ranges GE, Housley TJ, Bhargava A, Wilhelm SM, Shrikhande A. 2000. Discovery of a new class of p38 kinase inhibitors. Bioorg Med Chem Lett 10:2047-2050.
33. Elias JA, Zhu Z, Chupp G, Homer RJ. 1999. Airway remodeling in asthma. J Clin Invest 104:1001-1006.
34. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. 2003. New insights into the pathogenesis of asthma. J Clin Invest 111:291-297.
35. Emelyanov A, Fedoseev G, Abulimity A, Rudinski K, Fedulov A, Karabanov A, Barnes PJ. 2001. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 120:1136-1139.
36. English JM, Cobb MH. 2002. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23:40-45.
37. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S, Cobb MH. 1999. New insights into the control of MAP kinase pathways. Exp Cell Res 253:255-270.
38. Escott KJ, Belvisi MG, Birrell MA, Webber SE, Foster ML, Sargent CA. 2000. Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat. Br J Pharmacol 131:173-176.
39. Eynott PR, Nath P, Leung SY, Adcock IM, Bennett BL, Chung KF. 2003. Allergen-induced inflammation and airway epithelial and smooth muscle cell proliferation: Role of Jun N-terminal kinase. Br J Pharmacol 140:1373-1380.
40. Feoktistov I, Goldstein AE, Biaggioni I. 1999. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in mast cells. Mol Pharmacol 55:726-734.
41. Fernandes D, Guida E, Koutsoubos V, Harris T, Vadiveloo P, Wilson JW, Stewart AG. 1999. Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol 21:77-88.
42. Fitzgerald SM, Lee SA, Hall K, Chi DS, Krishnaswamy G. 2004. Human lung fibroblasts express IL-6 in response to signaling following mast cell contact. Am J Respir Cell Mol Biol 30:585-593.
43. Frantz B, Klatt T, Pang M, Parsons J, Rolando A, Williams H, Tocci MJ, O'Keefe SJ, O'Neill EA. 1998. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 37:13846-13853.
44. Furuichi S, Hashimoto S, Gon Y, Matsumoto K, Horie T. 2002. p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase regulate interleukin-8 and RANTES production in hyperosmolarity-stimulated human bronchial epithelial cells. Respirology 7:193-200.
45. Gallagher TF, Fier-Thompson SM, Garigipati RS, Sorenson ME, Smietana JM, Lee D, Lee JC, Laydon JT, Griswold DE, Chabot-Fletcher MC, Breton JJ, Adams JL. 1995. 2,4,5-Triarylimidazole inhibitors of IL-1 biosynthesis. Bioorg Med Chem Lett 5:1171-1176.
46. Gerthoffer WT, Singer CA. 2003. MAPK regulation of gene expression in airway smooth muscle. Respir Physiol Neurobiol 137:237-250.
47. Gonzalez MV, Gonzalez-Sancho JM, Caelles C, Munoz A, Jimenez B. 1999. Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells. FEBS Lett 459:272-276.
48. Gum RJ, McLaughlin MM, Kumar S, Wang Z, Bower MJ, Lee JC, Adams JL, Livi GP, Goldsmith EJ, Young PR. 1998. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem 273:15605-15610.
49. Haegeman G. 2003. Inhibition of signal transduction pathways involved in inflammation. Eur Respir J 22(Suppl 39):16s-19s.
50. Hall JP, Merithew E, Davis RJ. 2000. c-Jun N-terminal kinase (JNK) repression during the inflammatory response? Just say NO. Proc Natl Acad Sci USA 97:14022-14024.
51. Hallsworth MP, Moir LM, Lai D, Hirst SJ. 2001. Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle. Am J Respir Crit Care Med 164:688-697.
52. Hamid Q, Song Y, KotsimbosTC, Minshall E, Bai TR, Hegele RG, Hogg JC. 1997. Inflammation of small airways in asthma. J Allergy Clin Immunol 100:44-51.
53. Hansson A, Hehenberger K, Thoren M. 1996. Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I). Cell Biochem Funct 14:121-129.
54. Hartert TV, Peebles RS, Jr. 2000. Epidemiology of asthma: The year in review. Curr Opin PuIm Med 6:4-9.
55. 1 induces phenotypic modulation of human lung fibroblast to myofibroblast through c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 163:152-157.
56. Hashimoto S, Gon Y, Takeshita I, Maruoka S, Horie T. 2001b. IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun-NH2-terminal kinase-dependent pathway. J Allergy Clin Immunol 107:1001-1008.
57. Hedges JC, Singer CA, Gerthoffer WT. 2000. Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. Am J Resp Cell Mol Biol 23:86-94.
58. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. 2002. Multiple control of interleukin-8 gene expression. J Leukoc Biol 72:847-855.
59. Holgate ST. 1997. Asthma genetics: Waiting to exhale. Nat Genet 15:227-229.
60. Ip YT, Davis RJ. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK): From inflammation to development. Curr Opin Cell Biol 10:205-219.
61. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. 2002. p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. J Allergy Clin Immunol 109:649-657.
62. Ishizuka T, Okajima F, Ishiwara M, Iizuka K, Ichimonji I, Kawata T, Tsukagoshi H, Dobashi K, Nakazawa T, Mori M. 2001. Sensitized mast cells migrate toward the antigen: A response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase. J Immunol 167:2298-2304.
63. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. 1999. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160:1032-1539.
64. Jibiki I, Hashimoto S, Maruoka S, Gon Y, Matsuzawa A, Nishitoh H, Ichijo H, Horie T. 2003. Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates nitric oxide-induced activator protein-1 activation in human bronchial epithelial cells. Am J Respir Crit Care Med 167:856-861.
65. Johnson GL, Lapadat R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912.
66. Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA, Skov PS, Poulsen LK, Alam R. 2000. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 95:1911-1917.
67. Kankaanranta H, De Souza PM, Barnes PJ, Salmon M, Giembycz MA, Lindsay MA. 1999. SB203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils. J Pharmacol Exp Ther 290:621-628.
68. Karin M. 1998. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann NY Acad Sci 851:139-146.
69. Karin M, Zheng-gang L, Zandi E. 1997. AP-1 function and regulation. Curr Opin Cell Biol 9:240-246.
70. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC. 2001. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20:7108-7116.
71. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. 2003. Interleukin-4 and interleukin-13 signaling connection maps. Science 300:1527-1528.
72. Kharitonov SA, Barnes PJ. 2000. Clinical aspects of exhaled nitric oxide. Eur Respir J 16:781-792.
73. Knaus UG, Morris S, Dong HJ, Chernoff J, Bokoch GM. 1995. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science 269:221-223.
74. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1:94-97.
75. Kumar S, Boehm J, Lee JC. 2003. p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2:717-726.
76. Laporte JC, Moore PE, Abraham JH, Maksym GN, Fabry B, Panettieri RA, Jr., Shore SA. 1999. Role of ERK MAP kinases in responses of cultured human airway smooth muscle cells to IL-1β. Am J Physiol 277:L943-L951.
77. Laporte JC, Moore PE, Baraldo S, Jouvin M-H, Church TL, Schwartzman IN, Panettieri RA, Jr., Kinet J-P, Shore SA. 2001. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 164:141-148.
78. Larché M, Douglas SR, Kay AB. 2003. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111:450-463.
79. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR. 2000. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 20:4265-4274.
80. Lasa M, Brook M, Saklatvala J, Clark AR. 2001. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol 21:771-780.
81. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR. 2002. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22:7802-7811.
82. Lee JC, Badger AM, Griswold DE, Dunnington D, Trunch A, Votta B, White JR, Young PR, Bender PE. 1993. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann NY Acad Sci 696:149-170.
83. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
84. Lee JC, Kassis S, Kumar S, Badger A, Adams JL. 1999. p38 mitogen-activated protein kinase inhibitors: Mechanisms and therapeutic potentials. Pharmacol Ther 82:389-397.
85. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. 2000. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47:185-201.
86. Lehner MD, Schwoebel F, Kotlyarov A, Leist M, Gaestel M, Hartung T. 2002. Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection. J Immunol 168:4667-4673.
87. Li J, Kartha S, Iasvovskaia S, Tan A, Bhat RK, Manaligod JM, Page K, Brasier AR, Hershenson MB. 2002. Regulation of human airway epithelial cell IL-8 expression by MAP kinases. Am J Physiol Lung Cell Mol Physiol 283:L690-L699.
88. May GHW, Allen KE, Clark W, Funk M, Gillespie DAF. 1998. Analysis of the interaction between c-Jun and c-Jun N-termirial kinase in vivo. J Biol Chem 273:33429-33435.
89. McCubrey JA, Stratford May W, Duronio V, Mufson A. 2000. Serine/threonine phosphorylation in cytokine signal transduction. Leukemia 14:9-21.
90. Moore PE, Church TL, Chism DD, Panettieri RA, Jr., Shore SA. 2002. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: A role for ERK. Am J Physiol Lung Cell Mol Physiol 282:L847-L853.
91. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S, Shen MM. 2000. Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Scei USA 97:10454-10459.
92. Newton R, Holden N. 2003. Inhibitors of p38 mitogen-activated protein kinase: Potential as anti-inflammatory agents in asthma? Biodrugs 17:113-129.
93. Nick JA, Young SK, Brown KK, Avdi NJ, Arndt PG, Suratt BT, Janes MS, Henson PM, Worthen GS. 2000. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol 164:2151-2159.
94. O'Sullivan MP, Tyner JW, Holtzman MJ. 2003. Apoptosis in the airways: Another balancing act in the epithelial program. Am J Respir Cell Mol Biol 29:3-7.
95. Orsini MJ, Krymskaya VP, Eszterhas AJ, Benovic JL, Panettieri RA, Jr., Penn RB. 1999. MAPK superfamily activation in human airway smooth muscle: Mitogenesis requires prolonged p42/p44 activation. Am J Physiol 277:L479-L488.
96. Park H-S, Huh S-H, Kim M-S, Lee SH, Choi E-J. 2000. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc Natl Acad Sci USA 97:14382-14387.
97. Pelaia G, Cuda G, Vatrella A, Grembiale RD, De Sarro GB, Maselli R, Costanzo FS, Avvedimento VE, Rotiroti D, Marsico SA. 2001. Effects of glucocorticoids on activation of c-Jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells. Biochem Pharmacol 62:1719-1724.
98. Pelaia G, Cuda G, Vatrella A, Grembiale RD, Fratto D, Tagliaferri P, Maselli R, Costanzo FS, Marsico SA. 2003a. Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells. Am J Respir Cell Mol Biol 29:12-18.
99. Pelaia G, Vatrella A, Cuda G, Maselli R, Marsico SA. 2003b. Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sci 72:1549-1561.
100. Pelaia G, Cuda G, Vatrella A, Gallelli L, Fratto D, Gioffrè V, D'Agostino B, Caputi M, Maselli R, Rossi F, Costanzo FS, Marsico SA. 2004. Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells. J Cell Biochem. Published online: 29 June 2004. DOI: 10.1002/jcb.20124.
101. Pernis AB, Rothman PB. 2002. JAK-STAT signaling in asthma. J Clin Invest 109:1279-1283.
102. 1 expression in primary tracheal myocytes. Am J Respir Cell Mol Biol 18:736-740.
103. Ranger AM, Hodge MR, Gravallese EM, Oukka M, Davidson L, Alt FW, de la Brousse FC, Hoey T, Grusby M, Glimcher LH. 1998. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8:125-134.
104. Rider LG, Hirasawa N, Santini F, Beaven MA. 1996. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J Immunol 157:2374-2380.
105. Rogatsky I, Logan SK, Garabedian MJ. 1998. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc Natl Acad Sci USA 95:2050-2055.
106. Saccani S, Pantano S, Natoli G. 2002. p38-marking of inflammatory genes for increased NF-κB recruitment. Nat Immunol 3:69-75.
107. Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ. 1998. MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281:1668-1671.
108. Sousa AR, Lane SJ, Soh C, Lee TH. 1999. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of Jun N-terminal kinase and failure of prednisolone to inhibit Jun N-terminal kinase phosphorylation. J Allergy Clin Immunol 104:565-574.
109. Swantek JL, Cobb MH, Geppert TD. 1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: Glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol Cell Biol 17:6274-6282.
110. Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, Saito H. 2002. Smad-dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF-β. EMBO J 21:6473-6482.
111. Takimoto M, Oda K, Sasaki Y, Okada T. 1996. Endothelin-A receptor-mediated prostanoid secretion via autocrine and deoxyribonucleic acid synthesis via paracrine signaling in human bronchial epithelial cells. Endocrinology 137:4542-4550.
112. Tamura DY, Moore EE, Johnson JL, Zallen G, Aiboshi J, Silliman CC. 1998. p38 mitogen-activated protein kinase inhibition attenuates intercellular adhesion molecule-1 up-regulation on human pulmonary microvascular endothelial cells. Surgery 124:403-407.
113. Trautmann A, Schmid-Grendelmeier P, Kruger K, Crameri R, Akdis M, Akkaya A, Brocker E-B, Blaser K, Akdis CA. 2002. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol 109:329-337.
114. Tsang F, Koh AHM, Ting WL, Wong PTH, Wong WSF. 1998. Effects of mitogen-activated protein kinase kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro. Br J Pharmacol 125:61-68.
115. Umland SP, Schleimer RP, Johnston SL. 2002. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol Ther 15:35-50.
116. Underwood DC, Osborn RR, Kotzer CJ, Adams JL, Lee JC, Webb EF, Carpenter DC, Bochnowicz S, Thomas HC, Hay DW, Griswold DE. 2000. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther 293:281-288.
117. van den Bosch JMM, Westermann C, Aumann J, Edsbacker S, Ton-nesson M, Selroos O. 1993. Relationship between lung tissue and blood concentrations of inhaled budesonide. Biopharm Drug Dispos 14:455-459.
118. Ventura J-J, Roncero C, Fabregat I, Benito M. 1999. Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor α in fetal rat hepatocyte primary cultures. Hepatology 29:849-857.
119. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, Bonsignore G. 2003. Airway remodeling in asthma. Chest 123 (Suppl 3):417S-422S.
120. Wang Z, Harkins PC, Ulevitch RJ, Han J, Cobb MH, Goldsmith EJ. 1997. The structure of mitogen-activated protein kinase p38 at 2.1-angstrom resolution. Proc Natl Acad Sci USA 94:2327-2332.
121. Wang Z, Canagarajah BJ, Boehm JC, Kassisa S, Cobb MH, Young PR, Abdel-Meguid S, Adams JL, Goldsmith EJ. 1998. Structural basis of inhibitor selectivity in MAP kinases. Structure 6:1117-1128.
122. Whitmarsh AJ, Davis RJ. 1998. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem Sci 23:481-485.
123. Widmann C, Gibson S, Jarpe MB, Johnson GL. 1999. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 79:143-180.
124. Wills-Karp M, Chiaramonte M. 2003. Interleukin-13 in asthma. Curr Opin Pulm Med 9:21-27.
125. Wilson KP, Fitzgibbon MJ, Caron PR, Griffith JP, Chen W, McCaffrey PG, Chambers SP, Su MS. 1996. Crystal structure of p38 mitogen-activated protein kinase. J Biol Chem 271:27696-27700.
126. Winston LA, Hunter T. 1996. Intracellular signalling: Putting JAKs on the kinase MAP. Curr Biol 6:668-671.
127. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen C-YA, Shyu A-B, Muller M, Gaestel M, Resch K, Holtmann H. 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18:4969-4980.
128. Wuits WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM. 2003. N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells. Eur Respir J 22:43-49.
129. Xie X, Gu Y, Fox T, Coll JT, Fleming MA, Markland W, Caron PR, Wilson KP, Su MS. 1998. Crystal structure of JNK3: A kinase implicated in neuronal apoptosis. Structure 6:983-991.
130. Yamashita M, Kimura M, Kubo M, Shimizu C, Tada T, Perlmutter RM, Nakayama T. 1999. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc Natl Acad Sci USA 96:1024-1029.
131. Zhang F, Strand A, Robbins D, Cobb MH, Goldsmith EJ. 1994. Atomic structure of the MAP kinase ERK2 at 2.3 angstrom resolution. Nature 367:704-710.
132. Zhou L, Hershenson MB. 2003. Mitogenic signaling pathways in airway smooth muscle. Respir Physiol Neurobiol 137:295-308.
133. Zhou L, Tan A, Iasvovskaia S, Li J, Lin A, Hershenson MB. 2003. Ras and mitogen-activated protein kinase kinase kinase-1 coregulate activator protein- 1- and nuclear factor-κB-mediated gene expression in airway epithelial cells. Am J Respir Cell Mol Biol 28:762-769.